To use all functions of this page, please activate cookies in your browser.
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Pancrelipase is a form of enzyme therapy for the treatment of various digestive disorders, primarily Exocrine pancreatic insufficiency. It is a mixture of three digestive enzymes, amylase, protease (peptidase), and lipase, which are normally produced by the pancreas. Pancrelipase is used by people with cystic fibrosis whose pancreatic ducts are blocked with mucus. The blockage prevents digestive enzymes that are made by the pancreas from reaching the intestines, where they are needed for digestion. This is also used with people with Chronic pancreatitis.
|This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Pancrelipase". A list of authors is available in Wikipedia.|